1
Roll Calls
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Policy Area: Health
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (D-NJ)
Latest Action (2021-10-20): Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
Subjects: Advanced technology and technological innovations, Congressional oversight, Department of Health and Human Services, Drug safety, medical device, and laboratory regulation, Food and Drug Administration (FDA), Government information and archives, Health programs administration and funding, Health technology, devices, supplies
Filter by Yea, Nay, or Absent
How members voted on HR4369. 292 total positions across all roll calls for this bill.
| Member | Date | Question | Vote | Result |
|---|---|---|---|---|
| Robert B. Aderholt (R-Alabama) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Jake Auchincloss (D-Massachusetts) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Mark E. Amodei (R-Nevada) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Alma S. Adams (D-North Carolina) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Pete Aguilar (D-California) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Rick W. Allen (R-Georgia) | 2021-10-19 | 2/3 Yea-And-Nay | Nay | Passed |
| Jodey C. Arrington (R-Texas) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Sanford D. Bishop (D-Georgia) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Cliff Bentz (R-Oregon) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Stephanie I. Bice (R-Oklahoma) | 2021-10-19 | 2/3 Yea-And-Nay | Not Voting | Passed |
| Lauren Boebert (R-Colorado) | 2021-10-19 | 2/3 Yea-And-Nay | Nay | Passed |
| Gus M. Bilirakis (R-Florida) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Vern Buchanan (R-Florida) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Suzanne Bonamici (D-Oregon) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Joyce Beatty (D-Ohio) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Andy Barr (R-Kentucky) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Julia Brownley (D-California) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Ami Bera (D-California) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Brian Babin (R-Texas) | 2021-10-19 | 2/3 Yea-And-Nay | Nay | Passed |
| Donald S. Beyer (D-Virginia) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Mike Bost (R-Illinois) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Brendan F. Boyle (D-Pennsylvania) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Don Bacon (R-Nebraska) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Jim Banks (R-Indiana) | 2021-10-19 | 2/3 Yea-And-Nay | Nay | Passed |
| Nanette Diaz Barragán (D-California) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Jack Bergman (R-Michigan) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Andy Biggs (R-Arizona) | 2021-10-19 | 2/3 Yea-And-Nay | Nay | Passed |
| Lisa Blunt Rochester (D-Delaware) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Ted Budd (R-North Carolina) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Troy Balderson (R-Ohio) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| James R. Baird (R-Indiana) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Tim Burchett (R-Tennessee) | 2021-10-19 | 2/3 Yea-And-Nay | Nay | Passed |
| Ken Calvert (R-California) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| James E. Clyburn (D-South Carolina) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Kat Cammack (R-Florida) | 2021-10-19 | 2/3 Yea-And-Nay | Nay | Passed |
| John R. Carter (R-Texas) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Tom Cole (R-Oklahoma) | 2021-10-19 | 2/3 Yea-And-Nay | Not Voting | Passed |
| Ed Case (D-Hawaii) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Jim Costa (D-California) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Emanuel Cleaver (D-Missouri) | 2021-10-19 | 2/3 Yea-And-Nay | Not Voting | Passed |
| Henry Cuellar (D-Texas) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Kathy Castor (D-Florida) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Yvette D. Clarke (D-New York) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Steve Cohen (D-Tennessee) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Joe Courtney (D-Connecticut) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| André Carson (D-Indiana) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Judy Chu (D-California) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Eric A. "Rick" Crawford (R-Arkansas) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Joaquin Castro (D-Texas) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
| Katherine M. Clark (D-Massachusetts) | 2021-10-19 | 2/3 Yea-And-Nay | Yea | Passed |
Showing 50 of 292 positions. JavaScript-enabled view supports filter by Yea/Nay/Absent and pagination.
Interactive features require JavaScript. Static data shown above.
HR4369 is the National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021, introduced in the House of the 119th U.S. Congress by Rep. Pallone, Frank, Jr. [D-NJ-6] (D-NJ). National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA.
HR4369 was sponsored by Rep. Pallone, Frank, Jr. [D-NJ-6] (D-NJ). Cosponsors and roll-call positions are listed on this page.
As of 2021-10-20, HR4369 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions..
HR4369 has had 1 roll-call vote on record. The most recent: 2021-10-19 — 2/3 Yea-And-Nay (Passed).
HR4369 is categorized under "Health." Browse other bills in this area at /topic-health/.
Each member’s vote is shown on this page, with party affiliation, state, and the official vote question. Click any member to see their full voting record.